OHE Publications

OHE releases a number of publications throughout the year, authored by OHE team members and/or outside experts. All are free for download as pdf files; hard copies of some publications are available upon request.

A description of the OHE publications categories.


 

Grout, P., Jenkins, A. and Propper, C.

Monograph
May 2000

This paper examines general issues in the use of benchmarking as a measure of comparative performance, reviews the application of benchmarking in the public and private sectors, and then examines the application of benchmarking in the UK National Health Service (NHS). A key issue of concern is whether there should be a link between benchmarks and explicit financial rewards, and the implications for the form of the benchmark if such links are made.

Our main conclusions are:

Royce, R.

Monograph
March 2000

Writing on the future of Primary Care Groups/Trusts, and of Labour’s health service reforms in general, invites subsequent ridicule by those blessed with the clarity of vision hindsight provides. The fact is that only the brave or foolish posit with any certainty how these latest changes to the UK National Health Service (NHS) will unfold. Nevertheless, this paper paints some scenarios, and at the end attempts to predict the future of the reforms.

Kettler, H.

Monograph
February 2000

Health and economic development is positively linked. External investments are needed to break the vicious cycle of poor health and poverty plaguing less developed countries (LDCs).

Measured in disability adjusted life years (DALYs), the disease burden suffered per person in LDCs is twice that of people in established market economies (EMEs). The two regions also have distinct disease patterns with almost 40 percent of LDCs’ healthy years lost to communicable, maternal, and prenatal diseases as opposed to only 8 percent in EMEs.

Oliver, A.

Monograph
December 1999

Most health care systems are characterised by both purchasers (insurers, health authorities), who buy health care for a particular population, and providers (hospitals, primary care physicians), who supply health care services. In circumstances where the purchasers or providers bear any of the financial risk associated with covering a population, incentives to prefer to ‘risk select’ are present; i.e. purchasers will prefer to provide cover for people who are likely to require relatively little health care.

Locock, L. ed.

Seminar Briefing
October 1999

A number of important themes emerged, as well as some signals as to the leadership development needs of those charged with ensuring PCGs’ success.

They challenges they face are to:

Williams, P. and Clow, S.

Monograph
October 1999

This Conference on Genomics, Healthcare and Public Policy, organised by the Office of Health Economics in collaboration with the School of Public Policy, University College London, and Pharmaceutical Partners for Better Healthcare, examined the status and likely consequences of healthcare applications of genetics. Advances in genetics will open up opportunities for universities and industry, they will induce changes in the practice of medicine, and lead to alterations in the structure and organization of health services in many countries.

Gold, L. ed.

Seminar Briefing
September 1999
  • International and UK experience illustrates the difficulty of involving the publica in health caare priority setting in ways that enable politicians, managers and doctors to incorporate public preferences into practical decision making.
  • Many techniques for measuring public preferences fail to incorporate key concepts:
  • opportunity cost. What are people prepared to give up or have less of, in order to have more of something else? The public have to be asked to make trade-offs;

Goodwin, N. ed.

Seminar Briefing
July 1999

• The integration of health care is the defining theme of policy developments in the UK, US and New Zealand. The common element between the three countries has been the development of multipractice and multi-professional groups in primary care settings.

• International learning has become commonplace and has accelerated the introduction of innovations in the UK.

Croxson, B.

Monograph
April 1999

There is widespread criticism of organisational costs in the NHS. 'Reduce bureaucracy, release funds for patient care' has become a popular slogan. This so-called 'bureaucracy' may, however, be essential to delivering health care. The complexity of modern health care means that some organisational costs have to be incurred if the right health care is to go to the right people at the right time.

Mason, A.R., Towse, A. and Drummond, M.F.

Monograph
March 1999

Disease management is a term with multiple and ambiguous meanings. For some, it is purely a form of managing care. For others, it is ‘strategic planning’ by the pharmaceutical industry to market its products in a different way. In between these two ends of the semantic spectrum are a wide variety of interpretations and usage. Forms of health care management exist that embody all the principles of disease management, but which are given a different label. In this report, we explore different notions of disease management and consider their relevance to the NHS.

Pages